Cargando…
Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy
The tumor microenvironment (TME) plays a central role in regulating antitumor immune responses. As an important part of the TME, alternatively activated type 2 (M2) macrophages drive the development of primary and secondary tumors by promoting tumor cell proliferation, tumor angiogenesis, extracellu...
Autores principales: | He, Yuanyuan, de Araújo Júnior, Raimundo Fernandes, Cruz, Luis J., Eich, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540805/ https://www.ncbi.nlm.nih.gov/pubmed/34683963 http://dx.doi.org/10.3390/pharmaceutics13101670 |
Ejemplares similares
-
Multifunctional Role of Lipids in Modulating the Tumorigenic Properties of 4T1 Breast Cancer Cells
por: He, Yuanyuan, et al.
Publicado: (2022) -
Ceramide and palmitic acid inhibit macrophage-mediated epithelial–mesenchymal transition in colorectal cancer
por: de Araujo Junior, Raimundo Fernandes, et al.
Publicado: (2020) -
STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer
por: Cavalcante, Rômulo S., et al.
Publicado: (2021) -
Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin’s Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer
por: Jorquera-Cordero, Carla, et al.
Publicado: (2022) -
Nanoparticles targeting hematopoietic stem and progenitor cells: Multimodal carriers for the treatment of hematological diseases
por: Cruz, Luis J., et al.
Publicado: (2022)